Face to Face Top Stocks: Sorrento Therapeutics, Inc. (NASDAQ:SRNE), Aercap Holdings N.V. (NYSE:AER)

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $4.09 on the last trading session with an decrease of -2.62%, whereas, it previously closed at $4.2. The company has a market capitalization of $493.17 Million. The company traded shares of 2.08 Million on the trading day while its three month average volume stands at 2.87 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) produced diluted EPS of -1.93. The EPS estimate for next year as estimated by analysts is at -0.73 while EPS for next quarter is estimated at -0.34. Earnings per Share growth for this year is reported at 33.3, while the analysts estimated the EPS growth for next year at -0.73% and Earnings growth for next 5 years stands at 37% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -5.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stands at 23.26 and Price to Book or P/B for the most recent quarter stands at 2.38. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) are reported at 2.9 and 2.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stands at -38.7, -88.5 and -34.4 respectively

The trailing twelve month Revenue of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is reported at 21.2 Million with income of -203500000. The outstanding shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) are 120.58 Million. The institutional Ownership of the shares of 25.9 stands at 0.80%, this figure is decreased -0.03 in the last six months. The insider ownership for the shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is ticked at 29.37%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is the Mean Target Price estimated by the analysts which stands at 20.67. The 52 week high of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is placed at 8.25 and 52 week low is standing at 1.80.

Performance wise the shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) rose up 7.63% for the week, it also rise 107.61% for the monthly performance, while for the quarter it went down 55.51%. The shares increase 3.28% for the half year and flew up for the Year-To-Date performance. The shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shrinked -31.26% for the yearly performance.

Aercap Holdings N.V. (NYSE:AER)

Aercap Holdings N.V. (NYSE:AER) closed at $47.1 on the last trading session with an decrease of -2.69%, whereas, it previously closed at $48.4. The company has a market capitalization of $6.65 Billion. The company traded shares of 1.18 Million on the trading day while its three month average volume stands at 1.33 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Aercap Holdings N.V. (NYSE:AER) produced diluted EPS of 6.83. The EPS estimate for next year as estimated by analysts is at 7.18 while EPS for next quarter is estimated at 1.62. Earnings per Share growth for this year is reported at 4, while the analysts estimated the EPS growth for next year at 7.18% and Earnings growth for next 5 years stands at 3.22% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 21.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Aercap Holdings N.V. (NYSE:AER) is at 6.9 while the forward p/e is at 6.56. The P/S or Price to Sales ratio of Aercap Holdings N.V. (NYSE:AER) stands at 1.45 and Price to Book or P/B for the most recent quarter stands at 0.76. The Price to Free Cash Flow ratio or P/FCF is reported at 7.16. The quick ratio and the current ratio of Aercap Holdings N.V. (NYSE:AER) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Aercap Holdings N.V. (NYSE:AER) stands at 2.4, 11.6 and 5.2 respectively

The trailing twelve month Revenue of Aercap Holdings N.V. (NYSE:AER) is reported at 4.6 Billion with income of 1.02 Billion. The outstanding shares of Aercap Holdings N.V. (NYSE:AER) are 141.19 Million. The institutional Ownership of the shares of 99.2 stands at 0.80%, this figure is decreased -0.1 in the last six months. The insider ownership for the shares of Aercap Holdings N.V. (NYSE:AER) is ticked at 12.24%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Aercap Holdings N.V. (NYSE:AER) is the Mean Target Price estimated by the analysts which stands at 62.64. The 52 week high of Aercap Holdings N.V. (NYSE:AER) is placed at 58.30 and 52 week low is standing at 36.16.

Performance wise the shares of Aercap Holdings N.V. (NYSE:AER) fell down -1.05% for the week, it also rise 13.14% for the monthly performance, while for the quarter it went down 9.61%. The shares decrease -16.22% for the half year and flew up for the Year-To-Date performance. The shares of Aercap Holdings N.V. (NYSE:AER) shrinked -7.94% for the yearly performance.